• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Pain Therapeutics Inc

+ Add to Watchlist

PTIE:US

2.0200 USD 0.1500 8.02%

As of 17:20:00 ET on 12/17/2014.

Snapshot for Pain Therapeutics Inc (PTIE)

Open: 1.8400 Day's Range: 1.8400 - 2.1000 Volume: 325,929
Previous Close: 1.8700 52wk Range: 1.6100 - 6.2200 1-Yr Rtn: -49.12%

Stock Chart for PTIE

No chart data available.
  • PTIE:US 2.0200
  • 1D
  • 1M
  • 1Y
1.8700
Interactive PTIE Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for PTIE

Current P/E Ratio (ttm) 4.1224
Estimated P/E(12/2014) -
Relative P/E vs. SPX 0.2388
Earnings Per Share (USD) (ttm) 0.4900
Est. EPS (USD) (12/2014) -0.3000
Est. PEG Ratio -
Market Cap (M USD) 92.43
Shares Outstanding (M) 45.76
30 Day Average Volume 224,704
Price/Book (mrq) 2.2429
Price/Sale (ttm) 2.5825
Dividend Indicated Gross Yield -%
Cash Dividend (USD) 0.7500
Dividend Ex-Date 12/13/2012
5 Year Dividend Growth -
Next Earnings Announcement 02/04/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for PTIE

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for PTIE

Pain Therapeutics, Inc. develops drugs using it proprietary technology. The Company develops safer or more efficacious drugs for use in pain management, particularly in the area of opioid painkillers. Pain Therapeutics has products in clinical trials.

Remi BarbierChairman/President/CEONadav FriedmannCOO/Chief Medical Officer
Peter S RoddyVP/CFO
More Company Profile & Key Executives for PTIE

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil